(Q35843543)

10 August 2017

1 reference

title

Intranasal medications for the treatment of migraine and cluster headache (English)

1 reference

10 August 2017

1 reference

1 reference

2

Marcelo E Bigal

1 reference

10 August 2017

3

Stewart J Tepper

1 reference

10 August 2017

Alan M Rapoport

1

1 reference

PubMed ID

15270595

10 August 2017

Fred D Sheftell

series ordinal

4

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

10

1 reference

10 August 2017

671-685

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418100-00004

10 August 2017

0 references

cites work

Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine

1 reference

12 December 2020

Clinical pharmacokinetics of ergotamine in migraine and cluster headache

1 reference

12 December 2020

A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache

1 reference

12 December 2020

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

1 reference

12 December 2020

The clinical spectrum of migraine

1 reference

12 December 2020

A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group

1 reference

12 December 2020

One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study

1 reference

12 December 2020

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial

1 reference

12 December 2020

Prevalence and incidence of cluster headache in the Republic of San Marino

1 reference

12 December 2020

Office-based treatment of acute migraine with dihydroergotamine mesylate

1 reference

12 December 2020

Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings

1 reference

12 December 2020

Pharmacological actions of the main metabolites of dihydroergotamine

1 reference

12 December 2020

Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses

1 reference

12 December 2020

Sumatriptan: a decade of use and experience in the treatment of migraine

1 reference

12 December 2020

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

1 reference

12 December 2020

Beneficial effect of capsaicin application to the nasal mucosa in cluster headache

1 reference

12 December 2020

Dihydroergotamine nasal spray for the acute treatment of migraine

1 reference

12 December 2020

Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients

1 reference

12 December 2020

Intranasal lidocaine for cluster headache

1 reference

12 December 2020

Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study

1 reference

12 December 2020

Prevalence of migraine and cluster headache in Swedish men of 18

1 reference

12 December 2020

Bioavailability of dihydroergotamine in man

1 reference

12 December 2020

Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate

1 reference

12 December 2020

Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types

1 reference

12 December 2020

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

1 reference

12 December 2020

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents

1 reference

12 December 2020

Intranasal civamide for the treatment of episodic cluster headaches

1 reference

12 December 2020

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

1 reference

12 December 2020

Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group

1 reference

12 December 2020

Capsaicin and sensory neurones — a review

1 reference

12 December 2020

Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache

1 reference

12 December 2020

Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management

1 reference

12 December 2020

The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve

1 reference

12 December 2020

Transnasal butorphanol in the emergency department management of migraine headache

1 reference

12 December 2020

Intranasal civamide for the acute treatment of migraine headache

1 reference

12 December 2020

Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat.

1 reference

12 December 2020

Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study

1 reference

12 December 2020

Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial

1 reference

12 December 2020

The pharmacology of ergotamine and dihydroergotamine

1 reference

12 December 2020

Home administration of intramuscular DHE for the treatment of acute migraine headache

1 reference

12 December 2020

Butorphanol (Stadol): a study in problems of current drug information and control.

1 reference

12 December 2020

A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine

1 reference

12 December 2020

Dihydroergotamine: a review of its use in the treatment of migraine and other headaches

1 reference

12 December 2020

Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine

1 reference

12 December 2020

Basic mechanisms in vascular headache

1 reference

12 December 2020

Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group

1 reference

12 December 2020

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet

1 reference

12 December 2020

Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial

1 reference

12 December 2020

Dosing and administration of ergotamine tartrate and dihydroergotamine

1 reference

12 December 2020

10.2165/00023210-200418100-00004

Identifiers

DOI

1 reference

PubMed ID

15270595

Dimensions Publication ID

10 August 2017

0 references

1 reference

PubMed ID

15270595